Clinical Trial Update: A Randomised Clinical Trial Assessing the Efficacy and Safety of Mycophenolate Mofetil Versus Azathioprine for Induction of Remission in Treatment Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial comparing mycophenolate mofetil to azathioprine for induction of remission in patients with autoimmune hepatitis-primary biliary cirrhosis overlap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Hepatitis
• Biliary Cirrhosis

Drugs mentioned

• Azathioprine (azathioprine)
• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

Sponsor: Xiaoli Fan | Conditions: Autoimmune Hepatitis, Primary Biliary Cirrhosis | Phase 4 | Status: UNKNOWN